Press Releases

Press Releases

Astellas and Medivation, Inc. announced today that the first patients have been enrolled in TRUMPET (Treatment Registry for Outcomes in CRPC Patients), a prospective observational patient registry designed to better understand the unique needs and treatment patterns for patients with castration-resistant prostate cancer (CRPC). The registry will enroll and evaluate…

Press Releases

OWC Pharmaceutical Research Corp., today announced that its wholly owned subsidiary, One World Cannabis Ltd. ("the Company"), an Israel-based developer of cannabinoid-based therapies targeting a variety of different indications, is proud to announce it has received the first basic science study (lab) results on the effect of several combination of…

Press Releases

Pulmatrix, a clinical stage biopharmaceutical company developing innovative inhaled therapies for serious pulmonary diseases, today announced that it has entered into an ex-U.S. development agreement with Mylan N.V. (Nasdaq: MYL), one of the world's leading global pharmaceutical companies. The agreement is for PUR0200, a clinical stage bronchodilator therapy being studied…

Press Releases

Antares Pharma, Inc. today announced that Eamonn P. Hobbs, President and Chief Executive Officer, will present at the JMP Securities Life Sciences Conference on Tuesday, June 23, 2015 at 1:30 p.m. Eastern Time. A live webcast of the presentation will be available via the webcast tab under the Investor Information…

Press Releases

The Pharmaceutical Research and Manufacturers of America (PhRMA) today announced the election of five of its newest members to its Board of Directors. "Over the past couple of months, we have been pleased to welcome five exceptional leaders to PhRMA's Board," said John J. Castellani, PhRMA president and chief executive…

Press Releases

Chiasma, Inc., a U.S. privately held biopharma company, today announced the company has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for the marketing and sale of octreotide capsules, an investigational drug for the maintenance treatment of adults with acromegaly. The FDA…

Press Releases

Juniper Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development of therapeutics for women's health, announced today the first patient has been enrolled in a Phase II clinical trial of COL-1077, a 10% lidocaine bioadhesive gel that is intended as an acute-use anesthetic during minimally invasive gynecologic procedures. This…

Press Releases

ArmaGen, Inc., a privately held biotechnology company focused on developing revolutionary therapies to treat severe neurological disorders, announced today that it achieved a clinical milestone in its worldwide licensing and collaboration agreement with Shire plc (LSE: SHP, NASDAQ: SHPG). The milestone was achieved in conjunction with dosing patients in its…

Press Releases

Recipharm today announces that it has completeted the acquisition of OnTarget Chemistry in Uppsala, Sweden. OnTarget Chemistry is a fast growing CRO company with a turnover in 2014 of close to SEK 29 million that is specialized in medicinal chemistry offering synthesis and analytical services which include rare and demanding…

Press Releases

PTC Therapeutics, Inc. and BioMarin Pharmaceutical Inc. announced today that they will host an Industry Update Symposium on Advances in Duchenne Muscular Dystrophy (DMD) and Biomarkers on Monday, June 22nd from 10 am – 1 pm ET at the Le Parker Meridien in New York City. Leading experts in the…